ProfileGDS4177 / 211140_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 69% 70% 79% 76% 66% 72% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated90.3169
GSM603099KU-812 non-treated102.0670
GSM603098KCL-22 Imatinib-treated206.1579
GSM603097KCL-22 non-treated163.7476
GSM603102JURL-MK1 Imatinib-treated77.8266
GSM603101JURL-MK1 non-treated112.772